Results 101 to 110 of about 100,489 (213)

Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.

PLoS ONE, 2018
BackgroundHuman immunodeficiency virus/Acquired immunodeficiency syndrome associated morbidity and mortality has reduced significantly since the introduction of highly active antiretroviral therapy.
Genet Gebrehiwet Hailu, Dawit Gebregziabher Hagos, Amlsha Kahsay Hagos, Araya Gebreyesus Wasihun, Tsehaye Asmelash Dejene   +4 more
doaj   +1 more source

The Epidemiology of HIV‐1 Resistance to Two‐Drug Regimens in Multicenter Cohort From Poland—A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Concerns about antiretroviral therapy failure are growing among people with HIV receiving two‐drug regimens, as these schemes include fewer active agents, while the prevalence of transmitted resistance in HIV‐1 continues to increase.
Andrzej Załęski, Agnieszka Lembas, Joanna Osińska, Tomasz Dyda, Magdalena Suchacz, Justyna Stempkowska‐Rejek, Justyna Orzechowska, Alicja Wiercińska‐Drapało   +7 more
wiley   +1 more source

Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS

Patologìâ, 2013
As a result of the analysis of 330 archival patient’s cards of patients with HIV/AIDS who received highly active antiretroviral therapy with the inclusion of tenofovir in the treatment scheme, kidney affection has been fixed in 1,5 % of cases only in ...
E.V. Ryabokon, T.E. Onishenko, E.L. Koltunik   +2 more
doaj   +1 more source

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents. [PDF]

, 2018
HIV latency in resting CD4+ T cell represents a key barrier preventing cure of the infection with antiretroviral drugs alone. Latency reversing agents (LRAs) can activate HIV expression in latently infected cells, potentially leading to their elimination
DeChristopher, Brian A, Hardman, Clayton T, Ho, Stephen, Loy, Brian A, Marsden, Matthew D, Navab, Sara M, Ramirez, Christina M, Schrier, Adam J, Shimizu, Akira J, Wender, Paul A, Wu, Xiaomeng, Zack, Jerome A   +11 more
core   +1 more source

Cytopenias With HIV in the Era of Highly Active Antiretroviral Therapy: Are We Winning the Battle?

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aim Cytopenias remain among the most frequent hematologic complications of HIV infection, affecting treatment outcomes and quality of life. The introduction of highly active antiretroviral therapy has markedly reduced their incidence by restoring immune function and suppressing viral replication.
Emmanuel Ifeanyi Obeagu
wiley   +1 more source

Highly Active Antiretroviral Therapy

Citation: 'highly active antiretroviral therapy' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13213 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for ...
openaire   +2 more sources

Estimation of prevalence of periodontal disease and oral lesions and their relation to CD4 counts in HIV seropositive patients on antiretroviral therapy regimen reporting at District General Hospital, Raichur

Journal of Indian Society of Periodontology, 2015
Introduction: Acquired Immuno Deficiency Syndrome (AIDS) is a condition in which the body becomes susceptible to a host of opportunistic infections. This syndrome is a culmination of infection with a lenti virus called Human Immunodeficiency Virus (HIV ...
Jagganatha Rao Ravi, Tuthipat Ramachandra Gururaja Rao   +1 more
doaj   +1 more source

Viral dynamics of acute HIV-1 infection. [PDF]

, 1999
Viral dynamics were intensively investigated in eight patients with acute HIV infection to define the earliest rates of change in plasma HIV RNA before and after the start of antiretroviral therapy. We report the first estimates of the basic reproductive
Havlir, DV, Little, SJ, McLean, AR, Richman, DD, Spina, CA   +4 more
core  

Efficacy of Dolutegravir Plus Lamivudine in People With TB/HIV Co‐Infection Using a Rifampicin or Rifabutin‐Based Regimen: A Retrospective Observational Case Series

Immunity, Inflammation and Disease, Volume 14, Issue 3, March 2026.
ABSTRACT Introduction Co‐infection with tuberculosis (TB) is the leading cause of death in individuals infected with human immunodeficiency virus (HIV)‐1. Dolutegravir and lamivudine (DTG + 3TC) has recently been recommended as the preferred first‐line regimen for the treatment of new and treatment‐experienced HIV‐infected patients.
Jinhong He, Xiangxi He, Xiaoxin Xie, Yanhua Fu, Xingxing Luo, Yinshuang Peng, Bin Xu, Hai Long   +7 more
wiley   +1 more source

¿Qué opinan los médicos penitenciarios sobre el control de la infección por el VIH en las prisiones españolas?: Resultados del Estudio del Grupo de Trabajo en Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria (GEISESP)

Revista Española de Sanidad Penitenciaria
Se presentan los resultados del estudio realizado por el Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria (GEISESP) sobre la opinión de los facultativos penitenciarios en cuanto a la conveniencia o no de realizar el ...
P. Saiz De la Hoya, A. Marco, J. García-Guerrero   +2 more
doaj